Everolimus inhibits breast cancer cell growth through PI3K/AKT/mTOR signaling pathway
- Type
- Retraction
- Notice date
- 3/31/2025 0:00
- Journal
- Molecular Medicine Reports
- Publisher
- Spandidos
- Notice DOI
- 10.3892/mmr.2025.13508
- Original paper DOI
- 10.3892/mmr.2018.8769